Severe alopecia areata may be driven by broader immune activation than previously recognized, according to new research ...

At week 36, 42.4 and 27.4% of patients receiving baricitinib 4mg and baricitinib 2mg, respectively, achieved a SALT score of less than or equal to 20 compared with 4.5% of patients receiving placebo.

Credit: SUN Pharma. Leqselvi is supplied as a tablet containing 8mg of deuruxolitinib. Prior to initiating treatment with Leqselvi, certain evaluations and immunizations are recommended. Leqselvi ™ ...

This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often underrepresented in clinical trials New data show ...

"Early onset alopecia areata can be more severe, leading to extensive hair loss that frequently does not improve with topicals or corticosteroids often prescribed as first-line therapy," said Brittany ...

Eli Lilly Canada Inc. ("Lilly") announced today that Ontario leads the way as the first province to add Olumiant® for severe ...

Since she was a child, Brandi Jones struggled with hair loss—not minor shedding or overall thinning, but large bald spots that made her feel like her head looked “like a leopard or cheetah,” she says.

A study evaluates the risk for osteoporosis or osteopenia associated with 5-alpha reductase inhibitors in women with two types of hair loss: androgenetic alopecia and frontal fibrosing alopecia.

Rezpegaldesleukin is an investigational biologic therapy that targets the interleukin-2 receptor complex in the body in order to stimulate proliferation of inhibitory immune cells known as regulatory ...

In a cross-sectional study of patients with alopecia areata (AA), illness perceptions and stigma were found to be associated with worse quality of life and increased levels of anxiety and depression ...